Makes custom folding cartons, consumer-product packaging and security printing for pharmaceutical, consumer-goods and other business customers.
10-K for FY2025, filed Mar 31, 2026
Printed-products customers pay for shipped packaging and printing products, or when services are completed and accepted. Rental income comes from leases; securities commissions arise on each customer trade, lending earns interest and management fees on managed loans, and biotechnology revenue comes from Celios product sales.
10-K for FY2025, filed Mar 31, 2026
10-K for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$20.8M
10-K for FY2025, filed Mar 31, 2026
$20.8M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Printed Products
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
87%
FY2022: 63%
|
Printed Products, FY2025
$18.1M Sources
|
Sold outright |
|
Rental Income
Recurring
|
6.0% |
Rental Income, FY2025
$1.2M Sources
|
Recurring |
|
Commercial Lending
|
0.2% |
Commercial Lending, FY2025
$45K Sources
|
|
|
Commission
Usage-based
|
6.5% |
Commission, FY2025
$1.4M Sources
|
Usage-based |
|
Biotechnology
Sold outright
|
0.2% |
Biotechnology, FY2025
$38K Sources
|
Sold outright |
Packaging customers include companies in healthcare, consumer goods, food and beverage; the division also serves end users with security printing. Securities and investment management serves retail and institutional investors.
10-K for FY2025, filed Mar 31, 2026
10-K for FY2025, filed Mar 31, 2026
Concentration of Credit Risk - The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits.…View ↗
No. It lost $23.9M in FY2025.
10-K for FY2025, filed Mar 31, 2026
10-Q for Q2 FY2026, filed Aug 14, 2026
−$4.8MView ↗
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
Flat. Revenue was $20.8M in FY2025, about the same as the $20.3M of FY2021.
Biotechnology focus
The older report described biotechnology as investing in or acquiring BioHealth and BioMedical companies and advancing disease and airborne-defense programs. The latest report centers on research and intellectual property in therapeutic drugs, a sugar substitute and fragrance, with partner commercialization.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 31, 2026Biotechnology: (“Biotech”) Biotechnology, a science-driven industry sector that uses living organisms and molecular biology to produce…View ↗
Biotechnology: (“Biotech”) Biotechnology, a science-driven industry sector that uses living organisms and molecular biology to produce…View ↗
Lending focus
The older description emphasized buying equity stakes in banks and related financial companies alongside broad financial services. The latest presents APF as a commercial lender offering business credit, land development, inventory and equipment financing, and loan servicing.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 31, 2026Commercial Lending: American Pacific Bancorp (“APB”), is organized for the purposes of being a financial network holding company, focused…View ↗
Commercial Lending: American Pacific Financial, Inc. (“APF”) represents our Company’s commercial lending business line. APF provides…View ↗
Loading...